Alvotech is a privately-owned, multinational biopharmaceutical company that develops and manufactures biosimilar products for the treatment of cancer and autoimmune and inflammatory diseases. The company was founded in 2013 by chief executive and chairman of sister company Alvogen, Robert Wessman.